Mr Marcus Cumberbatch

Mr Marcus Cumberbatch is a leading consultant urological surgeon based in Sheffield and Nottingham, who specialises in prostate cancer, medicolegal work and prostate biopsy alongside bladder problems, benign prostate enlargement, kidney cancer and adult circumcision. He privately practises at The Thornbury Hospital, Spire Hospital Claremont and The Park Hospital, while his NHS base is Royal Hallamshire Hospital. He is also the Cancer Lead of the directorate.

Mr Cumberbatch has an impressive educational CV, with an MBBS from University College London and MRCS from the Royal College of Surgeons of England. As part of his medical school training, Mr Cumberbatch attended the Welcome Institute where he obtained a scholarship to complete an Intercalated BSc in the History of Medicine.

Further educational achievements include foundation training in the Nottingham Deanery, the Academic Clinical Fellowship and a PhD in Cancer Biology. He was also awarded an Academic Clinical Lectureship by the National Institute for Health Research (NIHR) and was granted the Ellison-Cliffe Foundation Award by the Royal Society of Medicine (RSM) where he learnt about robot-assisted surgery and novel cancer diagnostics in Melbourne, Australia.

Mr Cumberbatch is also highly experienced in the medicolegal aspects of urological surgery, preparing expert opinion reports on a wide range of conditions, including prostate, testicular, bladder, and kidney issues. He completes 4 to 8 reports per month, with an average turnaround of four weeks, and undertakes cases involving clinical negligence and personal injury. His expertise covers screening, breach of duty, causation, condition and prognosis reports.

While he primarily represents claimants, he also has experience with defendant cases and has provided oral evidence at Family and Coroners counsel meetings. He is committed to ensuring his reports meet the court's requirements, adhering to his duty of impartiality and accuracy. Mr Cumberbatch's medicolegal practice is underpinned by his extensive clinical experience, encompassing robotic, laparoscopic, and open surgical techniques, alongside his completion of the Royal Society of Medicine's legal day.

Mr Cumberbatch is highly respected among his peers, and he has presented at various international conferences in countries including Japan, Spain and Denmark. He holds several leadership positions including principal investigator on a number of NIHR portfolio clinical trials investigating the use of robotics in minimally-invasive surgery, patient outcome meetings and cancer screening.  

His clinical research has featured in a selection of peer-reviewed journals, and he has an international reputation for his cancer epidemiology knowledge. Mr Cumberbatch is a member of various professional organisations, including the European Association of Urology (EAU) and the Medical Defence Union (MDU). Furthermore, he's a fellow of the Royal College of Surgeons of Edinburgh.    

In 2021, Mr Cumberbatch published an international multicentre series showing that robotic surgery can be used even in high-risk situations where kidney function is poor or only one kidney is present. These patients previously may have been facing open surgery or lifelong dialysis, but with robotic techniques can now be offered a keyhole operation to remove the cancer with less complications, faster recovery, and preserved kidney function.